Andrew Reardon

LGND

Andrew Reardon serves as officer: CLO & Secretary at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

14 trades

$5.73M

Net Position

Net Seller

$5.73M

Companies Traded

LGND, LGNZZ, LGNDZ

Active Period

Mar 2023 – Apr 2026

14 total trades

Most Recent

Sell LGND

Apr 2, 2026 · $1.01M

Andrew Reardon's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

0 · $0.00

Sells

9 · $3.45M

Total Shares Bought

Total Shares Sold

25,700

LGND Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 2, 2026	Sell	5,000	$201.24	$1.01M	45,922
Mar 6, 2026	Sell	4,900	$206.50	$1.01M	41,769
Jun 24, 2025	Sell	500	$114.08	$57.0K	31,903
Jun 12, 2025	Sell	500	$114.54	$57.3K	32,403
Jun 2, 2025	Sell	1,000	$104.00	$104.0K	32,903
Sep 25, 2024	Sell	2,000	$99.60	$199.2K	22,534
Aug 30, 2024	Sell	1,500	$106.39	$159.6K	22,534
May 13, 2024	Sell	10,000	$83.04	$830.4K	22,205
Mar 28, 2023	Sell	300	$69.92	$21.0K	16,308

Andrew Reardon's Insider Trading at LIGAND PHARMS BETA CVR (LGNZZ)

Buys

0 · $0.00

Sells

1 · $1.78M

Total Shares Bought

Total Shares Sold

9,680

LGNZZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 14, 2026	Sell	9,680	$183.83	$1.78M	0

Andrew Reardon's Insider Trading at LIGAND PHARMS INC CVR (LGNDZ)

Buys

0 · $0.00

Sells

4 · $507.0K

Total Shares Bought

Total Shares Sold

4,222

LGNDZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Aug 10, 2025	Sell	1,325	$150.06	$198.8K
Jun 23, 2025	Sell	500	$114.08	$57.0K
Jun 10, 2025	Sell	500	$114.54	$57.3K
Aug 10, 2024	Sell	1,897	$102.18	$193.8K

Related Insiders

KOZARICH JOHN W

Director

LGNDSell · Apr 2, 2026

LAMATTINA JOHN L

Director

LGNDSell · Mar 31, 2026

Stephen L Sabba

director

LGNDSell · Mar 25, 2026

Octavio Espinoza

officer: Chief Financial Officer

LGNDSell · Mar 13, 2026

Octavio Espinoza

Chief Financial Officer

LGNZZSell · Feb 14, 2026

Todd C Davis

Chief Executive Officer

LGNZZSell · Feb 14, 2026

KOZARICH JOHN W

Director

LGNDZSell · Feb 2, 2026

Octavio Espinoza

Chief Financial Officer

LGNDZSell · Dec 12, 2025

Explore More Insider Trading Data

LGND Insider Trading Activity

View all insider trades at Ligand Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity